Louisiana State University Health Sciences Shreveport ( Site 0072) — Shreveport, Louisiana

Public research footprint of Louisiana State University Health Sciences Shreveport ( Site 0072), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

COVID-19 · Breast Neoplasms · Pneumococcal Disease · Severe Acute Respiratory Syndrome Coronavirus 2

Recently updated registry entries

NCT05543616 — A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy… (Completed)
NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)
NCT06966700 — A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Louisiana State University Health Sciences Shreveport ( Site 0072)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.